Mary L. Morris

CPG 7909, an Immunostimulatory TLR9 Agonist Oligodeoxynucleotide, as Adjuvant to Engerix-B� HBV Vaccine in Healthy Adults: A Double-Blind Phase I/II Study

Curtis Cooper, Heather L. Davis, Mary L. Morris et al. · Journal of Clinical Immunology · 2004 · 328 citations

Vaccination, Vaccine Development, Engerix-b� Hbv Vaccine +6

Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine

Curtis Cooper, Heather L. Davis, Mary L. Morris et al. · Vaccine · 2004 · 245 citations

Vaccination, Vaccine Safety, Cross-protection +9

CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in antiretroviral-treated HIV-infected adults

Curtis Cooper, Heather L. Davis, Jonathan B. Angel et al. · AIDS · 2005 · 191 citations

Co-administration of CpG oligonucleotides enhances the late affinity maturation process of human anti-hepatitis B vaccine response

Claire‐Anne Siegrist, Maria Pihlgren, Chantal Tougne et al. · Vaccine · 2004 · 107 citations

Vaccination, Vaccine Development, Viral Hepatitis +5

Deiodination of Diiodotyrosine by Cell-Free Systems

John B. Stanbury, Mary L. Morris · Journal of Biological Chemistry · 1958 · 72 citations · Full text

Engineering, Bioorganic Chemistry, Heterocyclic +4